Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

首页> 外文期刊>The lancet. Respiratory medicine. >Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

【24h】

Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

机译：严重哮喘患者的抗白细胞介素-5治疗：从临床试验到临床实践

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet. Respiratory medicine.》 |2020年第5期|共4页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice [J] . The lancet. Respiratory medicine. . 2020,第5期

机译：严重哮喘患者的抗白细胞介素-5治疗：从临床试验到临床实践
2. Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy [J] . R. Buhl European respiratory review . 2007,第104期

机译：抗IgE：尽管有优化的治疗方法，但对有严重过敏性哮喘症状的患者进行临床试验的经验教训
3. JAAD Game Changers: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD) [J] . Lake Eden Journal of the American Academy of Dermatology . 2019,第4期

机译：JAAD游戏变化器：杜帕里姆治疗在患者报告的结果（专业人士）中提供临床有意义的改善：成年患者中度至严重特应性皮炎（广告）的成人患者中的IIB，随机，安慰剂控制，临床试验
4. Patient in control in clinical trials - European initiatives for improving patient empowerment in clinical trials through technical implementation of legal norms [C] . Forgo Nikolaus, Goralczyk Magdalena, Hanold Stefanie Annual Conference of Japanese Society for Medical and Biological Engineering;Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2013

机译：在临床试验中控制患者-通过法律规范的技术实施来提高临床试验中患者的能力的欧洲倡议
5. Performance of a Rules-Based, Electronic Health Record-Driven Severe Asthma Case Finding Algorithm for Clinical Trial Recruitment [D] . Beuther, David Alan. 2019

机译：基于规则的临床试验招聘招聘中的基于规则的电子健康记录驱动的严重哮喘案例发现算法
6. Correction: Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials [O] . Yao Liu, Song Zhang, Dao-wei Li, -1

机译：校正：美泊利珠单抗抗白细胞介素5治疗哮喘的疗效：一项随机安慰剂对照试验的荟萃分析
7. PRS57 Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Greece: a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data [O] . Sonathi V., Hatzikou M., Baldwin M., 2014

机译：PRS57经济评估的Omalizumab与标准疗法相比，在希腊成年患者中治疗严重过敏性哮喘：基于临床试验和实际数据的成本效益分析

Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

著录项

相似文献

相关主题

期刊订阅